Syndrome d'excès d'aromatase (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Syndrome d'excès d'aromatase" in French language version.

refsWebsite
Global rank French rank
4th place
12th place
2nd place
3rd place
low place
3,196th place
3rd place
11th place
731st place
771st place
low place
low place
610th place
265th place

books.google.com

doi.org

dx.doi.org

  • Martin RM, Lin CJ, Nishi MY, et al., « Familial hyperestrogenism in both sexes: clinical, hormonal, and molecular studies of two siblings », The Journal of Clinical Endocrinology and Metabolism, vol. 88, no 7,‎ , p. 3027–34 (PMID 12843139, DOI 10.1210/jc.2002-021780, lire en ligne)
  • Stratakis CA, Vottero A, Brodie A, et al., « The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription », The Journal of Clinical Endocrinology and Metabolism, vol. 83, no 4,‎ , p. 1348–57 (PMID 9543166, DOI 10.1210/jc.83.4.1348, lire en ligne)
  • Fukami M, Shozu M, Ogata T, « Molecular bases and phenotypic determinants of aromatase excess syndrome », International Journal of Endocrinology, vol. 2012pages = 584807,‎ (PMID 22319526, PMCID 3272822, DOI 10.1155/2012/584807)
  • Binder G, Iliev DI, Dufke A, et al., « Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred », The Journal of Clinical Endocrinology and Metabolism, vol. 90, no 1,‎ , p. 484–92 (PMID 15483104, DOI 10.1210/jc.2004-1566, lire en ligne)
  • de Lignières B, Silberstein S, « Pharmacodynamics of oestrogens and progestogens », Cephalalgia : an International Journal of Headache, vol. 20, no 3,‎ , p. 200–7 (PMID 10997774, DOI 10.1046/j.1468-2982.2000.00042.x, lire en ligne)
  • Meinhardt U, Mullis PE, « The aromatase cytochrome P-450 and its clinical impact », Hormone Research, vol. 57, nos 5-6,‎ , p. 145–52 (PMID 12053085, DOI 10.1159/000058374)
  • Persson I, « Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings », The Journal of Steroid Biochemistry and Molecular Biology, vol. 74, no 5,‎ , p. 357–64 (PMID 11162945, DOI 10.1016/S0960-0760(00)00113-8, lire en ligne)

elsevier.com

linkinghub.elsevier.com

  • Persson I, « Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings », The Journal of Steroid Biochemistry and Molecular Biology, vol. 74, no 5,‎ , p. 357–64 (PMID 11162945, DOI 10.1016/S0960-0760(00)00113-8, lire en ligne)

endojournals.org

jcem.endojournals.org

  • Martin RM, Lin CJ, Nishi MY, et al., « Familial hyperestrogenism in both sexes: clinical, hormonal, and molecular studies of two siblings », The Journal of Clinical Endocrinology and Metabolism, vol. 88, no 7,‎ , p. 3027–34 (PMID 12843139, DOI 10.1210/jc.2002-021780, lire en ligne)
  • Stratakis CA, Vottero A, Brodie A, et al., « The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription », The Journal of Clinical Endocrinology and Metabolism, vol. 83, no 4,‎ , p. 1348–57 (PMID 9543166, DOI 10.1210/jc.83.4.1348, lire en ligne)
  • Binder G, Iliev DI, Dufke A, et al., « Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred », The Journal of Clinical Endocrinology and Metabolism, vol. 90, no 1,‎ , p. 484–92 (PMID 15483104, DOI 10.1210/jc.2004-1566, lire en ligne)

nih.gov

ncbi.nlm.nih.gov

  • Martin RM, Lin CJ, Nishi MY, et al., « Familial hyperestrogenism in both sexes: clinical, hormonal, and molecular studies of two siblings », The Journal of Clinical Endocrinology and Metabolism, vol. 88, no 7,‎ , p. 3027–34 (PMID 12843139, DOI 10.1210/jc.2002-021780, lire en ligne)
  • Stratakis CA, Vottero A, Brodie A, et al., « The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription », The Journal of Clinical Endocrinology and Metabolism, vol. 83, no 4,‎ , p. 1348–57 (PMID 9543166, DOI 10.1210/jc.83.4.1348, lire en ligne)
  • Fukami M, Shozu M, Ogata T, « Molecular bases and phenotypic determinants of aromatase excess syndrome », International Journal of Endocrinology, vol. 2012pages = 584807,‎ (PMID 22319526, PMCID 3272822, DOI 10.1155/2012/584807)
  • Binder G, Iliev DI, Dufke A, et al., « Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred », The Journal of Clinical Endocrinology and Metabolism, vol. 90, no 1,‎ , p. 484–92 (PMID 15483104, DOI 10.1210/jc.2004-1566, lire en ligne)
  • de Lignières B, Silberstein S, « Pharmacodynamics of oestrogens and progestogens », Cephalalgia : an International Journal of Headache, vol. 20, no 3,‎ , p. 200–7 (PMID 10997774, DOI 10.1046/j.1468-2982.2000.00042.x, lire en ligne)
  • Meinhardt U, Mullis PE, « The aromatase cytochrome P-450 and its clinical impact », Hormone Research, vol. 57, nos 5-6,‎ , p. 145–52 (PMID 12053085, DOI 10.1159/000058374)
  • Czajka-Oraniec I, Simpson ER, « Aromatase research and its clinical significance », Endokrynologia Polska, vol. 61, no 1,‎ , p. 126–34 (PMID 20205115, lire en ligne)
  • Persson I, « Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings », The Journal of Steroid Biochemistry and Molecular Biology, vol. 74, no 5,‎ , p. 357–64 (PMID 11162945, DOI 10.1016/S0960-0760(00)00113-8, lire en ligne)

sagepub.com

cep.sagepub.com

viamedica.pl

endokrynologia.polska.viamedica.pl

  • Czajka-Oraniec I, Simpson ER, « Aromatase research and its clinical significance », Endokrynologia Polska, vol. 61, no 1,‎ , p. 126–34 (PMID 20205115, lire en ligne)